The human coronavirus (HCoV), SARS-CoV-2, caused more than 34 M confirmed infections from which more than 1 M deaths are reported until now (the WHO situation report-154). The current pandemic causes severe socio-economic burden. Due to the importance of understanding of the mode of recognition and viral entry, spike protein shed drug designers as the first look protein target with the first released solved structure on 26 February 2020 (PDB ID: 6VSB). It is proposed that the recognition site for GRP78 is found in SARS-CoV-2 and the immersed human coronaviruses but experimental validation is still required.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, spike, GRP78, HSPA5, viral attachment, host-cell recognition, cross-vaccination, 【초록키워드】 coronavirus, pandemic, Infection, viral entry, Spike protein, Protein, death, experimental validation, PDB, human coronavirus, caused, reported, required, cause, the WHO, released, 【제목키워드】 Human, Recognition,
【저자키워드】 COVID-19, SARS-CoV-2, spike, GRP78, HSPA5, viral attachment, host-cell recognition, cross-vaccination, 【초록키워드】 coronavirus, pandemic, Infection, viral entry, Spike protein, Protein, death, experimental validation, PDB, human coronavirus, caused, reported, required, cause, the WHO, released, 【제목키워드】 Human, Recognition,